Országos Onkológiai Intézet

What Országos Onkológiai Intézet does

Országos Onkológiai Intézet (OOI) is Hungary's national public oncology institute and the country's only comprehensive cancer center, operating as a government state entity headquartered in Budapest at Ráth György utca 7-9. Established over 50 years ago, OOI delivers integrated cancer care across 12 clinical departments, including surgical oncology, radiotherapy, chemotherapy, diagnostic imaging, laboratory diagnostics, palliative care, and rehabilitation. The institute treats approximately 16,000 inpatients annually plus outpatient and day-treatment cases, serving as the national referral hub for oncology under Hungary's universal health insurance system (NEAK). It also operates the National Cancer Registry (Nemzeti Rákregiszter), the country's central epidemiological database for cancer cases.

OOI's research infrastructure includes the Oncology Biobank Center, the Redox Tumor Biology research platform (funded by HUF 928M through the NKFIH TKP2021 programme), and departments in molecular genetics, pharmacology, immunology, and selenium protein research. The institute introduced robot-assisted laparoscopic surgery to Hungary through the EU-funded EFOP project, partnering with Leipzig University and Salzburg Hospital for clinical training. Three Semmelweis University departments (Oncology, Thoracic Surgery, and Oncological and Thoracic Surgery) operate within OOI's campus, anchoring the institute's role in medical education and specialty training.

OOI's revenue model is based on publicly funded healthcare services reimbursed through Hungary's national health insurance system, supplemented by EU research grants and select paid services (Térítéses betegellátás) not covered by insurance. The institute coordinates Hungary's participation in multiple EU4Health joint actions (CraNE, eCAN, JANE, CCI4EU, ECHoS), spanning 16 to 28 countries, and contributes to the National Cancer Control Program targeting a 10% reduction in cancer mortality by 2030. OOI is led by Director General Prof. Dr. Dank Magdolna, with Prof. Dr. Nagy Péter serving as Scientific Director.

Name

Országos Onkológiai Intézet

Legal name

Országos Onkológiai Intézet

Website

https://onkol.hu

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Országos Onkológiai Intézet is Hungary's only comprehensive cancer center, providing integrated oncology care, research, and medical education through 12 clinical departments serving national cancer patients via the public health insurance system.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (62151)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology hospital services
• Cancer treatment center
• Surgical oncology
• Radiation therapy
• Cancer research

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Healthcare Services: As Hungary's only comprehensive cancer center, the institute provides publicly funded healthcare services through the national health insurance system, treating approximately 16,000 inpatients annually plus outpatient and day treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Országos Onkológiai Intézet is Hungary's only comprehensive cancer center, providing integrated oncology care across 12 clinical departments. Its core offerings include inpatient and outpatient cancer treatment, diagnostic services (pathology, laboratory, imaging), drug therapy (chemotherapy, immunotherapy), radiotherapy, surgical oncology, palliative care, rehabilitation, and psychological support. The institute also operates the National Cancer Registry, conducts clinical and translational research, and provides medical education including specialty training for oncologists.

Product overview

Orszagos Onkologiai Intezet (National Oncology Institute) is Hungary's sole comprehensive cancer center, providing integrated healthcare services across 12 clinical departments, research, and education. The institute offers inpatient and outpatient care, diagnostic services (pathology, laboratory, imaging), drug therapy (chemotherapy, immunotherapy), radiation therapy, surgical oncology, palliative care, and rehabilitation. It serves as the national hub for cancer treatment, research, and medical education, operating the National Cancer Registry and supporting international collaborations.

Differentiator

Problem solved

Functional benefit

Products and services

• Inpatient and Outpatient Cancer Treatment (Fekvő és járóbeteg ellátás) Comprehensive cancer treatment provided across 12 clinical departments through inpatient care, outpatient clinics, and day treatments. Services cover all tumor types including breast, lung, gastrointestinal, head and neck, melanoma, urological, and gynecological cancers. Approximately 16,000 inpatients are treated annually.
• Robotic Surgery (Robotsebészet) Robot-assisted laparoscopic surgery introduced to Hungary through the EFOP project, allowing for minimally invasive precise surgical interventions with 4 robotic arms, 3D visualization, and faster recovery times.
• Radiotherapy Services (Sugárterápiás Központ) Advanced radiotherapy treatment with clinical radiobiology, oncocytogenetics, and clinical radiation physics departments providing comprehensive radiation therapy services for cancer patients.
• Drug Therapy / Chemotherapy (Gyógyszerterápiás Központ) Drug therapy center with multiple specialized departments including Dermato-oncology, Hematology and Lymphoma, Thoracic/Abdominal Tumors and Clinical Pharmacology, and Urogenital Tumors providing chemotherapy and immunotherapy.
• Cancer Diagnostics (Diagnosztika) Comprehensive cancer diagnostics including Tumor Pathology Center (cytopathology, surgical and molecular tumor pathology), Laboratory Diagnostics Center, and Oncological Imaging and Invasive Diagnostics Center (isotope diagnostics, radiology).
• Rehabilitation Services (Rehabilitációs Központ) Rehabilitation services including physiotherapy and movement therapy, as well as psych-oncology support for cancer patients during and after treatment.
• Palliative Care (Palliatív Mobil Team) Palliative Mobile Team providing end-of-life care and pain management for cancer patients, including Pain Management Ambulance and interventional pain management services.
• Oncology Biobank (Onkológiai Biobank Központ) Biobank for storing biological samples for diagnostic and research purposes, with expansion planned for redox biology research.
• Medical Education and Specialty Training (Oktatás) Medical education programs including specialty training, continuing education for oncologists, and clinical trials training. Three departments of Semmelweis University (Department of Oncology, Department of Thoracic Surgery, Oncological and Thoracic Surgery Department) operate within the institute's walls.
• National Cancer Registry (Nemzeti Rákregiszter) National database maintaining information on cancer cases to support domestic cancer research efforts and epidemiological surveillance.
• Health Development Office (Egészségfejlesztési Iroda - EFI) Health Development Office providing education on cancer prevention, early detection, and healthy lifestyle for community health promotion.

Quantifiable outcome

• Reduce cancer mortality by 10% in Hungary by 2030
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered major and core.

• Organisation of European Cancer Institutes (OECI)majorStrategic or Co-development Partner · 1 May 2023Coordinator of CCI4EU project for strengthening research capacity in comprehensive oncology infrastructures across 36 organizations in 16 countries.
• Clinical Research and Biomedical Innovation Agency (AICIB, Portugal)majorStrategic or Co-development Partner · 1 April 2023Coordinator of ECHoS project creating National Cancer Mission Hubs across Europe. OOI leads 4 work packages.
• Slovenia National Institute of Public Health (NIJZ)majorStrategic or Co-development Partner · 1 October 2022Coordinator of the CraNE joint action - European Network of Comprehensive Cancer Centres. OOI serves as the designated competent authority in Hungary.
• IRCCS National Cancer Institute Foundation (Italy)majorStrategic or Co-development Partner · 1 October 2022Coordinator of JANE joint action creating networks of expertise in oncology. OOI serves as designated competent authority in Hungary.
• Sciensano Health Research Institute (Belgium)majorStrategic or Co-development Partner · 15 September 2022Coordinator of eCAN joint action on strengthening e-health, telemedicine, and remote monitoring in cancer care across EU member states.
• Leipzig University Urology Clinic (Germany)majorStrategic or Co-development Partner · 20 February 2021International clinical and scientific collaboration for robotic surgery training as part of the EFOP project for introducing robot-assisted laparoscopic surgery to Hungary.
• Salzburg St. John's Brothers Hospital Gynecology Department (Austria)majorStrategic or Co-development Partner · 20 February 2021International collaboration partner for robotic surgery training and knowledge transfer.
• Budapest Jahn Ferenc South-Pest Hospital and Outpatient Clinic (JFKH)majorStrategic or Co-development Partner · 20 February 2021Consortium partner in the EFOP project for introducing robot-assisted surgery to Hungary. Joint procurement of robotic surgical equipment.
• Semmelweis UniversitycoreStrategic or Co-development PartnerThree departments of Semmelweis University's Medical School operate within the institute: Department of Oncology, Department of Thoracic Surgery, and Oncological and Thoracic Surgery Department. Joint education and research activities.
• Karolinska Institute (Sweden)majorStrategic or Co-development PartnerJoint professional events on AI-supported oncology diagnostics, collaboration in medical education and research.
• European Commission / EU4Health ProgrammecoreStrategic or Co-development PartnerFunding and programmatic support through multiple joint actions: CraNE, JANE, CCI4EU, eCAN, ECHoS supporting cancer care improvement across Europe.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• European Institute of Oncology (IEO): Italy's specialized oncology research and treatment hospital; comparable as a specialty cancer hospital combining clinical care, research, and prevention in a single integrated institution.
• Maria Sklodowska-Curie National Research Institute of Oncology: Poland's national oncology research and treatment institute; a comparable public-sector comprehensive cancer center with research, inpatient, and outpatient services across multiple oncology specialties.
• IRCCS National Cancer Institute (Fondazione IRCCS 'Istituto Nazionale dei Tumori'): Italy's leading comprehensive cancer hospital and research center; a peer as a publicly funded European oncology hub with integrated clinical-research mission and an existing OOI partnership via the JANE joint action.
• Masaryk Memorial Cancer Institute: Czech Republic's national comprehensive cancer center providing multidisciplinary oncology care, research, and education; the most directly comparable peer given similar Central-Eastern European national mandate, public ownership, and integrated clinical-research model.

Broad incumbents

• Gustave Roussy Institute: One of Europe's largest comprehensive cancer centers based in France; a peer for European-wide oncology leadership, translational research scale, and EU joint action participation, though significantly larger and broader in scope.
• Vienna General Hospital (AKH) - Comprehensive Cancer Center: Austria's university-affiliated comprehensive cancer center; comparable as a public-sector Central-European oncology hub with integrated university hospital research and inpatient care.
• Karolinska Comprehensive Cancer Center: Sweden's university hospital oncology center; a peer as a publicly funded Nordic comprehensive cancer center with research leadership and existing OOI collaboration in AI-supported oncology diagnostics.
• National Cancer Institute (NCI, USA): The US federal cancer research and treatment agency; comparable as a publicly funded national oncology research and care institution with a national cancer registry and international research leadership, though far larger in scale and budget.
• Charité Comprehensive Cancer Center: Germany's large university hospital oncology program; comparable as an EU-region comprehensive cancer center with university medical school integration and significant EU research funding.

Others

• Organisation of European Cancer Institutes (OECI): European accreditation and networking body for comprehensive cancer centers; an ecosystem peer given OOI's partnership in CCI4EU to strengthen research capacity across OECI's 36 member organizations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@orszagosonkologiaiintezet7909
• Facebookfacebook.com/onkologiaiintezet
• Instagraminstagram.com/orszagosonkologiaiintezet

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Országos Onkológiai Intézet